Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2001-9-6
pubmed:abstractText
Single isomers of the selective serotonin reuptake inhibitors citalopram (escitalopram, S-citalopram) and fluoxetine (R-fluoxetine) are currently under development for the treatment of depression and other psychiatric disorders. Previous studies conducted in laboratory animals have revealed that the biological effects on serotonin reuptake for citalopram reside in the S enantiomer. In contrast, both enantiomers of fluoxetine contribute to its biological activity.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Carrier Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Citalopram, http://linkedlifedata.com/resource/pubmed/chemical/Dopamine Plasma Membrane Transport..., http://linkedlifedata.com/resource/pubmed/chemical/Fluoxetine, http://linkedlifedata.com/resource/pubmed/chemical/Membrane Glycoproteins, http://linkedlifedata.com/resource/pubmed/chemical/Membrane Transport Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Nerve Tissue Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Norepinephrine Plasma Membrane..., http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Neurotransmitter, http://linkedlifedata.com/resource/pubmed/chemical/SLC6A2 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/SLC6A4 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Serotonin Plasma Membrane..., http://linkedlifedata.com/resource/pubmed/chemical/Serotonin Uptake Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Symporters
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0006-3223
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
50
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
345-50
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:11543737-Animals, pubmed-meshheading:11543737-Binding, Competitive, pubmed-meshheading:11543737-Brain, pubmed-meshheading:11543737-Carrier Proteins, pubmed-meshheading:11543737-Citalopram, pubmed-meshheading:11543737-Dopamine Plasma Membrane Transport Proteins, pubmed-meshheading:11543737-Dose-Response Relationship, Drug, pubmed-meshheading:11543737-Fluoxetine, pubmed-meshheading:11543737-Humans, pubmed-meshheading:11543737-Membrane Glycoproteins, pubmed-meshheading:11543737-Membrane Transport Proteins, pubmed-meshheading:11543737-Nerve Tissue Proteins, pubmed-meshheading:11543737-Norepinephrine Plasma Membrane Transport Proteins, pubmed-meshheading:11543737-Receptors, Neurotransmitter, pubmed-meshheading:11543737-Serotonin Plasma Membrane Transport Proteins, pubmed-meshheading:11543737-Serotonin Uptake Inhibitors, pubmed-meshheading:11543737-Stereoisomerism, pubmed-meshheading:11543737-Structure-Activity Relationship, pubmed-meshheading:11543737-Symporters
pubmed:year
2001
pubmed:articleTitle
Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine.
pubmed:affiliation
Laboratory of Neuropsychopharmacology, Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, 1639 Pierce Drive, Atlanta, GA 30322, USA.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't